Kristin Stafford
Kristin Stafford is the Chief Financial Officer of Zymeworks, Inc., where she plays a pivotal role in overseeing the company's financial strategy and operations. Recently, she discussed Zymeworks' significant acquisition of Theravance Biopharma, highlighting the financing structure and the expected benefits from the deal, particularly regarding Yupelri royalties.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 7.00 | 0.08% | +0% | 38,005,238 | 29,738 | $1,700,000 | 1,330$ |
| Totals | 1 | 38,005,238 | 29,738 | $1,700,000 | 1,330$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Kristin Stafford, chief financial officer of Zymeworks, discussed the financing details of the Theravance deal during a conference call.
7